- Home
- LBRT vs ZLAB Comparison
LBRT vs ZLAB Comparison
Compare LBRT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LBRT | ZLAB |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.6B |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LBRT | ZLAB |
|---|---|---|
| Price | $12.95 | $26.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 12 |
| Target Price | $26.79 | ★ $34.13 |
| AVG Volume (30 Days) | ★ 5.1M | 1.1M |
| Earning Date | 10-21-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.20% | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $4,006,116,000.00 | $460,156,000.00 |
| Revenue This Year | $13.75 | N/A |
| Revenue Next Year | $7.19 | $22.41 |
| P/E Ratio | $79.09 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $11.24 | $15.96 |
| 52 Week High | $34.48 | $29.02 |
Technical Indicators
Market Signals| Indicator | LBRT | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 35.39 | 60.15 |
| Support Level | N/A | $24.24 |
| Resistance Level | $22.29 | $26.64 |
| Average True Range (ATR) | 1.13 | 1.30 |
| MACD | -0.26 | 0.50 |
| Stochastic Oscillator | 25.77 | 64.22 |
Price Performance
Historical ComparisonAbout LBRT Liberty Energy Inc.
Liberty Energy Inc is a integrated energy services and technology company focused on providing hydraulic fracturing services and related technologies to onshore oil and natural gas exploration and production (E&P) companies. The Company offers customers with hydraulic fracturing services, together with complementary services including wireline services, proppant delivery solutions, field gas processing and treating, compressed natural gas (CNG) delivery, data analytics, related goods (including sand mine operations), and technologies to facilitate lower emission completions, thereby helping customers reduce emissions profile. The company provides services across USA and Canada.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.